Edition:
India

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

16.70USD
12:47am IST
Change (% chg)

$-0.29 (-1.71%)
Prev Close
$16.99
Open
$16.96
Day's High
$17.13
Day's Low
$16.59
Volume
228,662
Avg. Vol
906,870
52-wk High
$27.32
52-wk Low
$11.57

Select another date:

Fri, Jan 18 2019

Photo

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

Jan 17 Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.

Select another date: